Millipore Sigma Vibrant Logo

516481 Pepstatin A, Synthetic - CAS 26305-03-3 - Calbiochem

Overview

Replacement Information

Key Spec Table

CAS #Empirical Formula
26305-03-3C₃₄H₆₃N₅O₉

Pricing & Availability

Catalogue Number AvailabilityPackaging Qty/Pack Price Quantity
516481-25MG
Retrieving availability...
Limited Availability
Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Plastic ampoule 25 mg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity is a multiple of
      Maximum Quantity is
      Upon Order Completion More Information
      You Saved ()
       
      Request Pricing
      516481-5MG
      Retrieving availability...
      Limited Availability
Limited Availability
      In Stock 
      Discontinued
      Limited Quantities Available
      Availability to be confirmed
        Remaining : Will advise
          Remaining : Will advise
          Will advise
          Contact Customer Service
          Contact Customer Service

          Plastic ampoule 5 mg
          Retrieving price...
          Price could not be retrieved
          Minimum Quantity is a multiple of
          Maximum Quantity is
          Upon Order Completion More Information
          You Saved ()
           
          Request Pricing
          Description
          OverviewA reversible inhibitor of aspartic proteases. Inhibits cathepsin D, pepsin, and renin. Reported to block apoptosis induced by CA-074 (Cat. No. 205530) in PC12 cell lines. Also available as a 25 mM solution in DMSO (Cat. No. 508437).
          Effective concentration: 1.0 µM.
          Catalogue Number516481
          Brand Family Calbiochem®
          SynonymsIva-Val-Val-Sta-Ala-Sta, Isovaleryl-Val-Val-4-amino-3-hydroxy-6-methylheptanoyl-Ala-4-amino-3-hydroxy-6-methylheptanoic Acid
          References
          ReferencesIsahara, K., et al. 1999. Neuroscience 91, 233.
          Kanamori, S., et al. 1998. Biochem. Biophys. Res. Commun. 251, 204.
          Szewczuk, Z., et al. 1992. Int. J. Pept. Prot. Res. 40, 233.
          Carraway, R.E., et al. 1991. Peptides 12, 107.
          Eid, M., et al. 1981. Biochem. J. 197, 465.
          Umezawa, H., et al. 1970. J. Antibiot. 23, 259.
          Product Information
          CAS number26305-03-3
          ATP CompetitiveN
          FormWhite solid
          Hill FormulaC₃₄H₆₃N₅O₉
          Chemical formulaC₃₄H₆₃N₅O₉
          Optical rotationOptical rotation: -90.0 ± 5° (c = 0.5, MeOH, 20°C).
          ReversibleY
          Quality LevelMQ100
          Applications
          Biological Information
          Primary Targetcathepsin D
          Primary Target IC<sub>50</sub>EC50 = 1.0 µM in blocking apoptosis induced by CA-074 in PC12 cell lines
          Purity≥98% by HPLC
          Physicochemical Information
          Cell permeableN
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          RTECSSC6155000
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Standard Handling
          Storage +2°C to +8°C
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 4 months at -20°C.
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications
          Global Trade Item Number
          Catalogue Number GTIN
          516481-25MG 07790788055837
          516481-5MG 04055977198836

          Documentation

          Pepstatin A, Synthetic - CAS 26305-03-3 - Calbiochem SDS

          Title

          Safety Data Sheet (SDS) 

          Pepstatin A, Synthetic - CAS 26305-03-3 - Calbiochem Certificates of Analysis

          TitleLot Number
          516481

          References

          Reference overview
          Isahara, K., et al. 1999. Neuroscience 91, 233.
          Kanamori, S., et al. 1998. Biochem. Biophys. Res. Commun. 251, 204.
          Szewczuk, Z., et al. 1992. Int. J. Pept. Prot. Res. 40, 233.
          Carraway, R.E., et al. 1991. Peptides 12, 107.
          Eid, M., et al. 1981. Biochem. J. 197, 465.
          Umezawa, H., et al. 1970. J. Antibiot. 23, 259.

          Brochure

          Title
          Western Blotting Tools

          Technical Info

          Title
          Protein Blotting Handbook: 6th Edition
          Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision11-October-2013 JSW
          SynonymsIva-Val-Val-Sta-Ala-Sta, Isovaleryl-Val-Val-4-amino-3-hydroxy-6-methylheptanoyl-Ala-4-amino-3-hydroxy-6-methylheptanoic Acid
          DescriptionA reversible inhibitor of aspartic proteases. Inhibits cathepsin D, pepsin, and renin. Reported to block apoptosis induced by CA-074 (Cat. No. 205530) in PC12 cells. Effective concentration: 1 µM.
          FormWhite solid
          Recommended reaction conditions
          Activity:
          Activity is measured by inhibition of pepsin. 1 U corresponds to the amount of inhibitor that reduces the activity of pepsin by 1 U (1 U of enzyme corresponds to the amount of enzyme that results in the increases the absorbance at 280 nm by 0.001 per min at pH 2.0, 37°C.)
          CAS number26305-03-3
          RTECSSC6155000
          Chemical formulaC₃₄H₆₃N₅O₉
          Purity≥98% by HPLC
          SolubilityDMSO (1 mg/ml) or Methanol (1 mg/ml)
          Storage +2°C to +8°C
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 4 months at -20°C.
          Toxicity Standard Handling
          Merck USA index14, 7147
          ReferencesIsahara, K., et al. 1999. Neuroscience 91, 233.
          Kanamori, S., et al. 1998. Biochem. Biophys. Res. Commun. 251, 204.
          Szewczuk, Z., et al. 1992. Int. J. Pept. Prot. Res. 40, 233.
          Carraway, R.E., et al. 1991. Peptides 12, 107.
          Eid, M., et al. 1981. Biochem. J. 197, 465.
          Umezawa, H., et al. 1970. J. Antibiot. 23, 259.